Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
Status:
Recruiting
Trial end date:
2023-01-21
Target enrollment:
Participant gender:
Summary
This prospective study aims to utilize pre- and mid-treatment PET-CT to guide de-escalation
of radiation therapy in HPV-related squamous cell carcinoma of the oropharynx.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center
Collaborators:
National Cancer Institute (NCI) VA Ann Arbor Healthcare System